Skip to main content
KBS_Icon_questionmark link-ico


Mishto Lab

We investigate the implications of proteasome-catalysed peptide splicing in tumour immunology, autoimmunity and in the CD8+ T cell response during infection, with the long-term aim to improve the efficacy of immunotherapy and vaccine development.

Furthermore, by applying a multi-scale and multi-disciplinary approach – thereby combining in silico, in vitro and in vivo strategies – we study how proteasome isoforms regulate the inflammation in the intracellular and extracellular space by degrading proteins and producing (pro)inflammatory peptides.


  1. CRUK Programm Fundation Award (2020-2026)
  2. BRC3-IIa (2019-2022)
  3. MPI-BPC collaborative contract (2018-2019)
  4. CRUK-KHP Development fund (2018-2019)
  5. Monash-KCL Seed fund (2018-2019)
  6. KCL-Charite joint call seed fund (2019-2020)

Our partners

Cancer Research UK